International Stem Cell Corp
OTC:ISCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
International Stem Cell Corp
OTC:ISCO
|
US |
|
Askoll Eva SpA
MIL:EVA
|
IT |
|
N
|
Novabase SGPS SA
ELI:NBA
|
PT |
|
CubeSmart
NYSE:CUBE
|
US |
|
Reliance Communications Ltd
NSE:RCOM
|
IN |
|
Lumine Group Inc
F:Z76
|
CA |
|
Banco do Brasil SA
OTC:BDORY
|
BR |
|
Sabina Gold & Silver Corp
TSX:SBB
|
CA |
|
Romande Energie Holding SA
SIX:HREN
|
CH |
|
A
|
AAR Corp
F:ARZ
|
US |
|
Tikehau Capital SCA
PAR:TKO
|
FR |
|
I
|
I-Tail PCL Corp
SET:ITC
|
TH |
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
DK |
|
Energy Fuels Inc
TSX:EFR
|
US |
|
Gold Road Resources Ltd
ASX:GOR
|
AU |
|
F
|
Flywire Corp
NASDAQ:FLYW
|
US |
|
Chemours Co
NYSE:CC
|
US |
|
B
|
Bank of America Corp
SIX:BAC
|
US |
|
S
|
Sime Darby Bhd
KLSE:SIME
|
MY |
|
MSCI Inc
NYSE:MSCI
|
US |
|
3
|
3M Co
XMUN:MMM
|
US |
|
K
|
Konami Group Corp
XMUN:KOA
|
JP |
|
A
|
Ageas SA
MIL:AGS
|
BE |
|
Transocean Ltd
NYSE:RIG
|
CH |
Bankruptcy Probability
International Stem Cell Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
International Stem Cell Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
International Stem Cell Corp
OTC:ISCO
|
1.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
International Stem Cell Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, International Stem Cell Corp has total debt of 3.3m USD. This includes both short-term (3.3m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
